Comparison of the pharmacokinetics and pharmacodynamics of S‐1 between Caucasian and East Asian patients von Chuah, Benjamin, Goh, Boon‐Cher, Lee, Soo‐Chin, Soong, Richie, Lau, Fayce, Mulay, Marilyn, Dinolfo, Melissa, Lim, Siew‐Eng, Soo, Ross, Furuie, Taro, Saito, Kaku, Zergebel, Christopher, Rosen, Lee S.

Volltext

Electrocardiographic Characterization of the QTc Interval in Patients with Advanced Solid Tumors: Pharmacokinetic- Pharmacodynamic Evaluation of Sunitinib von Bello, Carlo L, Mulay, Marilyn, Huang, Xin, Patyna, Shem, Dinolfo, Melissa, Levine, Steven, Van Vugt, Andrew, Toh, Melvin, Baum, Charles, Rosen, Lee

Volltext

Safety, Pharmacokinetics, and Efficacy of AMG 706, an Oral Multikinase Inhibitor, in Patients With Advanced Solid Tumors von ROSEN, Lee S, KURZROCK, Razelle, XU, Ren Y, POLVERINO, Anthony, WIEZOREK, Jeffrey S, CHANG, David D, BENJAMIN, Robert, HERBST, Roy S, MULAY, Marilyn, VAN VUGT, Andy, PURDOM, Michelle, NG, Chaan, SILVERMAN, Jeffrey, KOUTSOUKOS, Antonis, SUN, Yu-Nien, BASS, Michael B

Volltext

Safety and Pharmacokinetics of Ganitumab (AMG 479) Combined with Sorafenib, Panitumumab, Erlotinib, or Gemcitabine in Patients with Advanced Solid Tumors von ROSEN, Lee S, PUZANOV, Igor, MITA, Alain C, MITA, Monica M, MULAY, Marilyn, SHUBHAKAR, Poornima, MIN ZHU, SARANTOPOULOS, John, FRIBERG, Gregory, CHAN, Emily, HWANG, Yuying C, HONGJIE DENG, GILBERT, Jill, MAHALINGAM, Devalingam, MCCAFFERY, Ian, MICHAEL, Shaunita A

Volltext

A phase 1b, open-label study of trebananib plus bevacizumab or motesanib in patients with solid tumours von Hong, David S, Kurzrock, Razelle, Mulay, Marilyn, Rasmussen, Erik, Wu, Benjamin M, Bass, Michael B, Zhong, Zhandong D, Friberg, Greg, Rosen, Lee S

Volltext